EUVIMEDEUVIMED entdecken
Crossref

Health-Related Quality of Life Among Individuals With Histiocytic Neoplasms in the Modern Era of Targeted Therapies

David L Pottinger, Luqin Deng, Dongni Yi, Alana E Gill, Matthew Slief, Jithma P Abeykoon, Saurabh Zanwar, Gordon Ruan, Daniel Sokolowski, Ene M Enogela, Rachelle Rouse, Kathleen Brewer und 12 weitere

Journal of the National Comprehensive Cancer Network · 09.11.2026 · 1-8

DOI: 10.6004/jnccn.2026.7062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 09.11.2026. Verfasst von David L Pottinger und 23 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Histiocytic neoplasms include Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), and Rosai-Dorfman disease (RDD). The discovery of MAPK pathway mutations has led to the approval of BRAF and MEK inhibitors, reducing disease-specific mortality. There is a critical need to define the health-related quality of life (HRQoL) among adults with histiocytic neoplasms in the modern era of targeted therapies.

Methods

We conducted a multi-institutional study including 196 adults with histiocytic neoplasms (73 LCH, 67 ECD, and 56 RDD) who completed the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 + 2 Profile v2.1, including 48 with longitudinal assessments. A total of 113 (57.7%) patients were not receiving treatment at the time of baseline survey. Primary endpoints were physical health (PH) and mental health (MH) summary scores, and the secondary outcome was the PROMIS Preference (PROPr) score, an overall health utility metric.

Results

Patients with ECD had worse PH scores than those with LCH or RDD (odds ratio [OR], 4.82; P =.006). Single-system pulmonary LCH (OR, 5.99; P =.028) and multisystem disease (OR, 2.49; P =.018) were also associated with worse PH scores than single-system disease. Multisystem disease was associated with worse MH scores (OR, 2.17; P =.036). An exploratory mixed-model longitudinal analysis (n=48) demonstrated improvements in PH scores among patients with ECD and in MH and PROPr scores among those with LCH over a median follow-up of 6 months.

Conclusions

Within histiocytic neoplasms, ECD and multisystem involvement define a high-risk HRQoL phenotype characterized by multidomain impairment. Longitudinal data suggest potential improvements in select domains with targeted therapy. However, mean scores remained below population norms. These patients may benefit from proactive, bundled supportive care and closer HRQoL monitoring.

Schlagwörter

Stichwörter der Autor:innen

HRQoLPROMshistiocytic neoplasmshistiocytosis

Autor:innen und Institutionen

  • 1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • 2Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • 3Mayo Clinic, Rochester, MN.
  • 4School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • 5Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • 6Hematology/Oncology Pharmacy, University of Alabama at Birmingham, Birmingham, AL.

Zitieren

APA

Pottinger, D. L., Deng, L., Yi, D., Gill, A. E., Slief, M., Abeykoon, J. P., Zanwar, S., Ruan, G., Sokolowski, D., Enogela, E. M., Rouse, R., Brewer, K., Fournier, D., Silvers, J., Ravindran, A., Morlote, D., Taylor, R., Shea, L. K., Saha, A., …, & Goyal, G. (2026). Health-Related Quality of Life Among Individuals With Histiocytic Neoplasms in the Modern Era of Targeted Therapies. Journal of the National Comprehensive Cancer Network, 1-8. https://doi.org/10.6004/jnccn.2026.7062

Vancouver

Pottinger DL, Deng L, Yi D, Gill AE, Slief M, Abeykoon JP, et al. Health-Related Quality of Life Among Individuals With Histiocytic Neoplasms in the Modern Era of Targeted Therapies. Journal of the National Comprehensive Cancer Network. 2026:1-8. doi:10.6004/jnccn.2026.7062

BibTeX
@article{Pottinger2026,
  author = {Pottinger, David L and Deng, Luqin and Yi, Dongni and Gill, Alana E and Slief, Matthew and Abeykoon, Jithma P and Zanwar, Saurabh and Ruan, Gordon and Sokolowski, Daniel and Enogela, Ene M and Rouse, Rachelle and Brewer, Kathleen and Fournier, Deanna and Silvers, Jen and Ravindran, Aishwarya and Morlote, Diana and Taylor, Richard and Shea, Lauren K and Saha, Aditi and Bhatia, Smita and D'Souza, Anita and Diamond, Eli L and Go, Ronald and Goyal, Gaurav},
  title = {Health-Related Quality of Life Among Individuals With Histiocytic Neoplasms in the Modern Era of Targeted Therapies},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  pages = {1--8},
  doi = {10.6004/jnccn.2026.7062}
}
Kostenlos starten →